Category: Therapeutic Area
Global Therapeutic Area
-
Hormone Replacement Therapy (HRT)
... reach US$44.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.3% CAGR ... Read More
-
Kidney Stone Management Devices
... reach US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 ... Read More
-
Infertility Treatment
... at a CAGR of 7.6% over the analysis period 2023-2030. Infertility Treatment Equipment, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end ... Read More
-
Ophthalmic Lasers
... at a CAGR of 5.0% over the analysis period 2023-2030. Femtosecond Lasers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$757.4 Million by the end of ... Read More
-
Sex Toys
... at a CAGR of 7.8% over the analysis period 2023-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of ... Read More
-
Allergy Diagnostics
... at a CAGR of 10.2% over the analysis period 2023-2030. Allergy Diagnostics Assay Kits, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$4.5 Billion by the ... Read More
-
Antidepressants
... of 2.5% over the analysis period 2023-2030. Antidepressants market for Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end ... Read More
-
Ophthalmic Pharmaceutical Drugs
... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Anti-VEGF Agents Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$34.3 ... Read More
-
Cardiology IT Workflow Solutions
... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
Optical Coherence Tomography (OCT) for Ophthalmology
... the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Conventional OCT Systems, one of the segments analyzed in the report, is expected ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Kidney Dialysis Equipment and Supplies
... is expected to reach US$32.9 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Hemodialysis Equipment and Supplies, one of the segments analyzed in the report, is expected to record ... Read More
-
Metabolic Testing Solutions
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$324.1 Million by ... Read More
-
Dental Preventive Supplies
... by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. The U.S. Market is Estimated at US$151.4 Million While China is Forecast to Grow at 6.4% CAGR The Dental Preventive Supplies market ... Read More
-
Narcolepsy Therapeutics
... at a CAGR of 7.2% over the analysis period 2023-2030. Narcolepsy with Cataplexy Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the ... Read More
-
Orthopedic Devices
... at a CAGR of 6.3% over the analysis period 2023-2030. Joint Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$44.6 Billion by the end ... Read More
-
EEG, EMG and Evoked Potential Devices
... the year 2023, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Electroencephalograph Equipment, one of the segments analyzed in the report, is expected to ... Read More
-
Food Allergy and Intolerance Products
... is expected to reach US$53.9 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Lactose-Free Products, one of the segments analyzed in the report, is expected to record a 5.1% ... Read More
-
Overactive Bladder (OAB) Therapeutics
... reach US$1.5 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Anticholinergics Therapy, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach ... Read More
-
Bone and Joint Health Supplements
... is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Joint Supplements, one of the segments analyzed in the report, is expected to record a 6.3% ... Read More
-
Testosterone Replacement Therapy (TRT)
... reach US$2.5 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. TRT Topicals, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More
-
Irritable Bowel Syndrome (IBS) Therapeutics
... is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. IBS-D Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% ... Read More
-
Peptic Ulcer Testing
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$410.6 Million by ... Read More
-
Infection Surveillance Solutions
... by 2030, growing at a CAGR of 14.2% over the period 2023-2030. Infection Surveillance Software, one of the segments analyzed in the report, is expected to record 13.7% CAGR and reach US$1.2 Billion by the ... Read More
-
Breast Biopsy Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$983.4 Million ... Read More
Research Assistance
